DrugEx

The premium Open Source alternative to Iktos Makya

🎯 Best for:Multi-objective optimization of molecules using RL.

What is DrugEx?

Replaces proprietary drug discovery AI platforms. It combines reinforcement learning with sequence-based models to optimize molecules for specific targets.

Tech Stack
Jupyter NotebookPharma & Biotechnology

Why DrugEx?

  • Multi-objective optimization
  • Transformer support
  • RL-driven

Limitations

  • Training instability
  • High memory usage
  • Complex reward shaping
3/3/2026
Last Update
26
Forks
5
Issues
MIT
License
Financial Leak Detected

Stop the "SaaS Tax"

Your team could be burning cash. Switching to DrugEx instantly boosts your runway.

Competitor Cost
-$1,440
/ year (est. based on Iktos Makya)
Self-Hosted
$0
/ year
Team Size10 Users
150+
SAVE 100%

Community Discussion

Comments